Cargando…

Right Hemispheric Predominance of Brain Infarcts in Atrial Fibrillation: A Lesion Mapping Analysis

Detalles Bibliográficos
Autores principales:	Altermatt, Anna, Sinnecker, Tim, Aeschbacher, Stefanie, Springer, Anne, Coslovsky, Michael, Beer, Juerg, Moschovitis, Giorgio, Auricchio, Angelo, Fischer, Urs, Aubert, Carole E., Kühne, Michael, Conen, David, Osswald, Stefan, Bonati, Leo H., Wuerfel, Jens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Stroke Society 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8829476/ https://www.ncbi.nlm.nih.gov/pubmed/35135070 http://dx.doi.org/10.5853/jos.2021.03531

Ejemplares similares

Sex differences of vascular brain lesions in patients with atrial fibrillation
por: Ceylan, Selinda, et al.
Publicado: (2022)

A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF)
por: Springer, Anne, et al.
Publicado: (2020)

Brain lesions and cognitive decline in patients with atrial fibrillation
por: Hennings, E, et al.
Publicado: (2023)

Blood Pressure and Brain Lesions in Patients With Atrial Fibrillation
por: Aeschbacher, Stefanie, et al.
Publicado: (2020)

Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates
por: Polymeris, Alexandros A, et al.
Publicado: (2020)

Cardiac autonomic function and cognitive performance in patients with atrial fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Association of Heart Rate Variability With Silent Brain Infarcts in Patients With Atrial Fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)

Alcohol consumption and risk of cardiovascular outcomes and bleeding in patients with established atrial fibrillation
por: Reddiess, Philipp, et al.
Publicado: (2021)

Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation
por: Witassek, Fabienne, et al.
Publicado: (2019)

Biomarker, Imaging, and Clinical Factors Associated With Overt and Covert Stroke in Patients With Atrial Fibrillation
por: De Marchis, Gian Marco, et al.
Publicado: (2023)

Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2022)

Neurocognitive function in patients with atrial fibrillation undergoing pulmonary vein isolation
por: Zwimpfer, Leon, et al.
Publicado: (2022)

The Omega-3 Fatty Acid Eicosapentaenoic Acid (EPA) Correlates Inversely with Ischemic Brain Infarcts in Patients with Atrial Fibrillation
por: Reiner, Martin F., et al.
Publicado: (2021)

Association of the CHA(2)D(S(2))-VASc Score and Its Components With Overt and Silent Ischemic Brain Lesions in Patients With Atrial Fibrillation
por: Steiner, Fabienne, et al.
Publicado: (2021)

Silent brain infarcts impact on cognitive function in atrial fibrillation
por: Kühne, Michael, et al.
Publicado: (2022)

Biomarkers, Clinical Variables, and the CHA(2)DS(2)-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients
por: Krisai, Philipp, et al.
Publicado: (2021)

Mid-term changes in cognitive functions in patients with atrial fibrillation: a longitudinal analysis of the Swiss-AF cohort
por: Wueest, Alexandra S., et al.
Publicado: (2023)

Association of statin use and lipid levels with cerebral microbleeds and intracranial hemorrhage in patients with atrial fibrillation: A prospective cohort study
por: Moutzouri, Elisavet, et al.
Publicado: (2023)

Long-term risk of adverse outcomes according to atrial fibrillation type
por: Blum, Steffen, et al.
Publicado: (2022)

Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
por: Girod, Marc, et al.
Publicado: (2022)

Association of psychosocial factors with all‐cause hospitalizations in patients with atrial fibrillation
por: Meyre, Pascal B., et al.
Publicado: (2020)

Biomarkers of Inflammation and Risk of Hospitalization for Heart Failure in Patients With Atrial Fibrillation
por: Benz, Alexander P., et al.
Publicado: (2021)

Omega‐3 Fatty Acids and Heart Rhythm, Rate, and Variability in Atrial Fibrillation
por: Baumgartner, Philipp, et al.
Publicado: (2023)

Association of cardiac rhythm with cognitive performance in atrial fibrillation patients
por: Mosher, L, et al.
Publicado: (2023)

Heart rate and adverse outcomes in patients with prevalent atrial fibrillation
por: Moschovitis, Giorgio, et al.
Publicado: (2021)

Heart Rate Variability Triangular Index as a Predictor of Cardiovascular Mortality in Patients With Atrial Fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2020)

Risk factors for heart failure hospitalizations among patients with atrial fibrillation
por: Eggimann, Lucien, et al.
Publicado: (2018)

Incidence and Predictors of Atrial Fibrillation Progression
por: Blum, Steffen, et al.
Publicado: (2019)

Symptoms and quality of life in patients with coexistent atrial fibrillation and atrial flutter
por: Stempfel, Samuel, et al.
Publicado: (2020)

Prospective Assessment of Sex‐Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation
por: Blum, Steffen, et al.
Publicado: (2017)

Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss‐AF Study
por: Bano, Arjola, et al.
Publicado: (2021)

Change in Atrial Fibrillation Burden over Time in Patients with Nonpermanent Atrial Fibrillation
por: Krisai, Philipp, et al.
Publicado: (2020)

Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation
por: Hennings, Elisa, et al.
Publicado: (2023)

Biomarkers associated with rhythm status after cardioversion in patients with atrial fibrillation
por: Meyre, Pascal B., et al.
Publicado: (2022)

C-reactive protein for prediction of atrial fibrillation recurrence after catheter ablation
por: Meyre, Pascal B., et al.
Publicado: (2020)

Estimating the cost impact of atrial fibrillation using a prospective cohort study and population-based controls
por: Aebersold, Helena, et al.
Publicado: (2023)

Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation
por: Hennings, Elisa, et al.
Publicado: (2023)

Bone morphogenetic protein 10 as a predictor for recurrent atrial fibrillation after catheter ablation
por: Hennings, E, et al.
Publicado: (2023)

Cryoballoon Ablation of Atrial Fibrillation Without Demonstration of Pulmonary Vein Occlusion—The Simplify Cryo Study
por: Kühne, Michael, et al.
Publicado: (2021)

Determinants of Left Atrial Volume in Patients with Atrial Fibrillation
por: Bossard, Matthias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v4v89ln3bcgn31cfnlufmutlp6